Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Spinal Cord Stimulation for Chronic and Intractable Back Pain

This study has been terminated.
(Insufficient Data Collected)
Sponsor:
Information provided by (Responsible Party):
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT00370695
First received: August 30, 2006
Last updated: August 1, 2013
Last verified: August 2013

August 30, 2006
August 1, 2013
February 2006
July 2008   (final data collection date for primary outcome measure)
The primary objective of this study is to evaluate back pain severity at 12 weeks post-activation as compared to baseline. [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
  • The primary objective of this study is to evaluate back pain severity at 12 weeks post-activation as compared to baseline.
  • Cumulative frequency of adverse events.
Complete list of historical versions of study NCT00370695 on ClinicalTrials.gov Archive Site
  • The secondary objectives of this study are to determine the long-term efficacy of this treatment and the impact of treatment on quality of life and disability measures, medication use, and costs associated with medical interventions and drug use for back [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Cumulative frequency of adverse events [ Time Frame: Throughout study ] [ Designated as safety issue: Yes ]
The secondary objectives of this study are to determine the long-term efficacy of this treatment and the impact of treatment on quality of life and disability measures, medication use, and costs associated with medical interventions and drug use for back
Not Provided
Not Provided
 
Spinal Cord Stimulation for Chronic and Intractable Back Pain
Spinal Cord Stimulation for Chronic and Intractable Back Pain in Patients Who Are Not Surgical Candidates

The purpose of this study is to evaluate the efficacy of spinal cord stimulation (SCS) using the Precision implantable neurostimulation device for chronic and intractable back pain in subjects who are not candidates for surgery or who have chosen to seek alternative therapy.

Management of symptoms of chronic back pain and/or lumbar radiculopathy is often difficult and inadequate. Current treatment options include pharmacological treatments, physical therapy, nerve blocks, surgical interruption of the pain pathway, or back surgery. Many patients either do not have adequate pain management with conventional treatments or are not able to tolerate the treatments due to significant side effects. Similarly, many patients are either not candidates for surgical interventions, or are unwilling to undergo such procedures. Spinal cord stimulation has proven to be an effective treatment for patients with pain following a failed back surgery, and this study will investigate spinal cord stimulation as a treatment option for the treatment of chronic back pain in patients who have never had back surgery. A successful study outcome will establish spinal cord stimulation as a less-invasive treatment option to be considered prior to surgery.

Interventional
Phase 4
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Back Pain
Device: Precision Spinal Cord Stimulation System
Stimulation turned on from implant throughout the Study
Active Comparator: Precision Spinal Cord Stimulation System
Single arm Precision Spinal Cord Stimulation System.
Intervention: Device: Precision Spinal Cord Stimulation System
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
15
July 2008
July 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Have chronic and intractable neuropathic back pain and/or lumbar radiculopathy of moderate to severe intensity and have elected Spinal Cord Stimulation (SCS) as next line of treatment.
  • Be 18 years of age or older.
  • Be an appropriate candidate for the surgical procedures required for SCS implant.
  • Be willing and able to comply with all study related procedures and visits.
  • Be capable of reading and understanding patient information materials and giving written informed consent.

Exclusion Criteria:

  • Have had any back or spine surgery.
  • Have any evidence of neurologic instability or any anatomic problem of the spine that requires surgery.
  • Have any other chronic pain conditions likely to confound evaluation of study endpoints.
  • Are a current substance abuser (including alcohol and illicit drugs).
  • Have a significant psychiatric disorder.
  • Have a condition currently requiring or likely to require the use of MRI or diathermy.
  • Have an active implantable device.
  • Are pregnant or lactating or planning to become pregnant in the next year.
  • Have participated in any drug or device trial in the last 4 weeks or plan to participate in any other study during the year.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00370695
SCS-03-05
No
Boston Scientific Corporation
Boston Scientific Corporation
Not Provided
Principal Investigator: Michael Huntley, MD Huntley Pain Specialists
Boston Scientific Corporation
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP